Neutralizing antibodies against adenovirus type 2 in normal and HIV-1-infected subjects: Implications for use of Ad2 vectors in vaccines

• Hauptverfasser: Qianqian Li (Verfasst von), Qiang Liu (Verfasst von), Weijing Huang (Verfasst von), Aijing Song (Verfasst von), Chenyan Zhao (Verfasst von), Jiajing Wu (Verfasst von), Youchun Wang (Verfasst von)
• Format: Buch
• Veröffentlicht: Taylor & Francis Group, 2017-06-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Pre-existing neutralizing antibodies (NAbs) directed against vaccine vectors have attracted considerable research attention. Therefore, our aim was to establish a high-throughput economical neutralization assay to investigate the epidemiology of adenovirus type 2 (Ad2)-specific immunity in China and...